Sesame Lipid Profile Randomized Trial Evidence Table

Structured evidence table for Sesame Lipid Profile Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Sesame Lipid Profile Randomized TrialThis comprehensive systematic review and meta-analysis aimed to assess the impact of sesame (Sesamum indicum L.) supplementation on cardiovascular disease risk factors.1Jafari A (2025)Clinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.
Sesame Lipid Profile Randomized TrialThe assessment of study quality was conducted using the Cochrane risk-of-bias tool.1Jafari A (2025)Clinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.
Sesame Lipid Profile Randomized TrialSubgroup analyses revealed that sesame supplementation significantly reduced CRP and malondialdehyde (MDA) in populations without chronic diseases, while total cholesterol (TC) and MDA were reduced in those with chronic diseases.1Jafari A (2025)Clinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.
Sesame Lipid Profile Randomized TrialRelevant research was discovered via PubMed, Scopus, Web of Science, CENTRAL, and EMBASE up to June 2024.1Jafari A (2025)Clinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.
Sesame Lipid Profile Randomized TrialDiabetes mellitus and dyslipidemia are significant health concerns that elevate the risk of cardiovascular disease and other metabolic disorders, necessitating effective management strategies.1Fornari Laurindo L (2025)Evaluating the effects of seed oils on lipid profile, inflammatory and oxidative markers, and glycemic control of diabetic and dyslipidemic patients: a systematic review of clinical studies.
Sesame Lipid Profile Randomized TrialRecent research has highlighted the potential role of dietary fats, particularly seed oils, in influencing health outcomes in these conditions.1Fornari Laurindo L (2025)Evaluating the effects of seed oils on lipid profile, inflammatory and oxidative markers, and glycemic control of diabetic and dyslipidemic patients: a systematic review of clinical studies.
topicSesame Lipid Profile Randomized Trial
claimThis comprehensive systematic review and meta-analysis aimed to assess the impact of sesame (Sesamum indicum L.) supplementation on cardiovascular disease risk factors.
evidence level1
citationJafari A (2025)
sourceClinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.
topicSesame Lipid Profile Randomized Trial
claimThe assessment of study quality was conducted using the Cochrane risk-of-bias tool.
evidence level1
citationJafari A (2025)
sourceClinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.
topicSesame Lipid Profile Randomized Trial
claimSubgroup analyses revealed that sesame supplementation significantly reduced CRP and malondialdehyde (MDA) in populations without chronic diseases, while total cholesterol (TC) and MDA were reduced in those with chronic diseases.
evidence level1
citationJafari A (2025)
sourceClinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.
topicSesame Lipid Profile Randomized Trial
claimRelevant research was discovered via PubMed, Scopus, Web of Science, CENTRAL, and EMBASE up to June 2024.
evidence level1
citationJafari A (2025)
sourceClinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.
topicSesame Lipid Profile Randomized Trial
claimDiabetes mellitus and dyslipidemia are significant health concerns that elevate the risk of cardiovascular disease and other metabolic disorders, necessitating effective management strategies.
evidence level1
citationFornari Laurindo L (2025)
sourceEvaluating the effects of seed oils on lipid profile, inflammatory and oxidative markers, and glycemic control of diabetic and dyslipidemic patients: a systematic review of clinical studies.
topicSesame Lipid Profile Randomized Trial
claimRecent research has highlighted the potential role of dietary fats, particularly seed oils, in influencing health outcomes in these conditions.
evidence level1
citationFornari Laurindo L (2025)
sourceEvaluating the effects of seed oils on lipid profile, inflammatory and oxidative markers, and glycemic control of diabetic and dyslipidemic patients: a systematic review of clinical studies.

Source documents

  1. Clinical evidence of sesame (Sesamum indicum L.) products and its bioactive compounds on anthropometric measures, blood pressure, glycemic control, inflammatory biomarkers, lipid profile, and oxidative stress parameters in humans: a GRADE-assessed systematic review and dose-response meta-analysis.
  2. Evaluating the effects of seed oils on lipid profile, inflammatory and oxidative markers, and glycemic control of diabetic and dyslipidemic patients: a systematic review of clinical studies.